Correlation Between ACELYRIN, INC and Ambrx Biopharma
Can any of the company-specific risk be diversified away by investing in both ACELYRIN, INC and Ambrx Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ACELYRIN, INC and Ambrx Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ACELYRIN, INC Common and Ambrx Biopharma American, you can compare the effects of market volatilities on ACELYRIN, INC and Ambrx Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ACELYRIN, INC with a short position of Ambrx Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of ACELYRIN, INC and Ambrx Biopharma.
Diversification Opportunities for ACELYRIN, INC and Ambrx Biopharma
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between ACELYRIN, and Ambrx is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding ACELYRIN, INC Common and Ambrx Biopharma American in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ambrx Biopharma American and ACELYRIN, INC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ACELYRIN, INC Common are associated (or correlated) with Ambrx Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ambrx Biopharma American has no effect on the direction of ACELYRIN, INC i.e., ACELYRIN, INC and Ambrx Biopharma go up and down completely randomly.
Pair Corralation between ACELYRIN, INC and Ambrx Biopharma
If you would invest 1,573 in Ambrx Biopharma American on August 31, 2024 and sell it today you would earn a total of 0.00 from holding Ambrx Biopharma American or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 4.55% |
| Values | Daily Returns |
ACELYRIN, INC Common vs. Ambrx Biopharma American
Performance |
| Timeline |
| ACELYRIN, INC Common |
| Ambrx Biopharma American |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
ACELYRIN, INC and Ambrx Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ACELYRIN, INC and Ambrx Biopharma
The main advantage of trading using opposite ACELYRIN, INC and Ambrx Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ACELYRIN, INC position performs unexpectedly, Ambrx Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ambrx Biopharma will offset losses from the drop in Ambrx Biopharma's long position.| ACELYRIN, INC vs. Inflection Point Acquisition | ACELYRIN, INC vs. Sabre Corpo | ACELYRIN, INC vs. Griffon | ACELYRIN, INC vs. Sapiens International |
| Ambrx Biopharma vs. Immix Biopharma | Ambrx Biopharma vs. Cns Pharmaceuticals | Ambrx Biopharma vs. Sonnet Biotherapeutics Holdings | Ambrx Biopharma vs. Enveric Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |